Investigational Site Number : 250001

Toulouse 31403

0 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Hematological Malignancy, Hypercholesterolaemia, Neoplasm Malignant

Studies at this site

• Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies — Completed
• Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin) — Completed
• First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor — Completed
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed